Ginkgo Bioworks Holdings, Inc.
DNA
$6.85
$0.162.39%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -33.92% | 33.70% | 15.42% | -90.65% |
| Total Depreciation and Amortization | 5,235.12% | -98.94% | 2.78% | 40.30% | 183.07% |
| Total Amortization of Deferred Charges | -66.43% | -- | -- | -- | -64.66% |
| Total Other Non-Cash Items | 102.78% | -21.37% | -24.33% | -24.61% | 39.95% |
| Change in Net Operating Assets | -271.21% | 160.66% | -96.39% | -630.75% | 102.22% |
| Cash from Operations | -50.85% | 21.48% | 21.87% | -21.41% | 59.00% |
| Capital Expenditure | -- | 100.00% | 99.50% | 44.41% | 9.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -90.36% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 229.82% | -14.04% | 66.58% | -33,737.68% | -86.78% |
| Cash from Investing | 230.60% | -13.97% | 67.84% | -1,418.41% | -28.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.17% | 75.51% | 52.66% | -1.97% | -1.50% |
| Issuance of Common Stock | -11.29% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -177.46% | -- | -- | -- | 100.00% |
| Cash from Financing | -18.07% | 10,240.82% | 52.66% | -1.97% | 56.34% |
| Foreign Exchange rate Adjustments | -263.44% | -50.00% | 151.35% | 201.37% | -108.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 158.70% | 9.29% | 58.43% | -348.67% | 51.14% |